Camurus AB (publ)
General ticker "CAMRF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.6B (TTM average)
Camurus AB (publ) follows the US Stock Market performance with the rate: 27.8%.
Estimated limits based on current volatility of 0.2%: low 54.91$, high 55.24$
Factors to consider:
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [35.50$, 68.44$]
- 2025-12-31 to 2026-12-31 estimated range: [34.64$, 66.52$]
Short-term CAMRF quotes
Long-term CAMRF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | SEK1,716.85MM | SEK1,867.58MM | SEK2,265.38MM |
| Operating Expenses | SEK1,190.95MM | SEK1,398.42MM | SEK1,391.45MM |
| Operating Income | SEK525.90MM | SEK469.17MM | SEK873.93MM |
| Non-Operating Income | SEK23.40MM | SEK83.36MM | SEK59.16MM |
| Interest Expense | SEK1.34MM | SEK1.08MM | SEK5.76MM |
| R&D Expense | SEK637.70MM | SEK683.62MM | SEK516.91MM |
| Income(Loss) | SEK549.30MM | SEK552.52MM | SEK933.09MM |
| Taxes | SEK117.86MM | SEK124.13MM | SEK197.52MM |
| Profit(Loss)* | SEK336.98MM | SEK387.62MM | SEK597.21MM |
| Stockholders Equity | SEK1,493.00MM | SEK3,289.68MM | SEK4,235.41MM |
| Inventory | SEK100.95MM | SEK140.22MM | SEK111.62MM |
| Assets | SEK1,907.82MM | SEK3,757.01MM | SEK4,739.98MM |
| Operating Cash Flow | SEK606.88MM | SEK387.99MM | SEK869.30MM |
| Capital expenditure | SEK10.13MM | SEK29.37MM | SEK138.52MM |
| Investing Cash Flow | SEK-10.13MM | SEK-29.37MM | SEK-138.52MM |
| Financing Cash Flow | SEK28.76MM | SEK1,300.67MM | SEK158.30MM |
| Earnings Per Share** | SEK5.86 | SEK6.68 | SEK10.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.